Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01587820 · ClinicalTrials.gov registry record · Early Phase 1

Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer

A Early Phase 1 study, sponsored by Southern Illinois University.

Terminated
Registry status
Early Phase 1
Development phase
1
Enrollment target

NCT01587820: Clinical Trial Early Phase 1 study, sponsored by Southern Illinois University.

NCT01587820 is a Early Phase 1 study that was terminated before completion, run by Southern Illinois University. The registered enrollment target is 1 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01587820, a Early Phase 1 study, was terminated before completion, sponsored by Southern Illinois University.

TERMINATED
Registry status
Early Phase 1
Development phase
1 participants
Enrollment target

Study Summary

This is a randomized, open-label investigator initiated pilot/ feasibility study comparing the effectiveness of intra-arterial administration of cisplatin therapy to intravenous administration of cisplatin when each is combined with the radiation therapy found in standard care. Participants will be randomized to either intra-arterial or intravenous cisplatin chemotherapy. This study is designed to determine whether a large scale study is practical in the investigators clinical setting. Approximately 10 subjects will be enrolled over a 2 year period.

Primary Outcome

enrollment

Interventions

  • DRUG Intra-arterial cisplatin
  • DRUG Intravenous cisplatin

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2012-06
Est. Completion 2014-08
Phase Early Phase 1
Southern Illinois University

21 total trials

Why NCT01587820 stopped before completion

NCT01587820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Intra-arterial cisplatin is the first listed.

NCT01587820 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01587820 about?

NCT01587820 is a clinical study titled "Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer". This is a randomized, open-label investigator initiated pilot/ feasibility study comparing the effectiveness of intra-arterial administration of cisplatin therapy to intravenous administration of cisplatin when each is combined with the radiation therapy found in standard care. Participants will be ...

What is the current status of trial NCT01587820?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2012-06. Estimated completion is 2014-08.

What interventions are being tested in trial NCT01587820?

The interventions under investigation include: Intra-arterial cisplatin (DRUG), Intravenous cisplatin (DRUG).

Who is sponsoring clinical trial NCT01587820?

This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01587820's enrollment target sits among peer trials

1 1985th of 2000 the lowest of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01587820, the US trial registry maintained by the National Library of Medicine. NCT01587820 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.